IM Cannabis Corp. Enters into Letter of Intent to Sell its European Activities, Expects to Significantly Reduce Debt by CAD$10.5 million
IM Cannabis Announces Form F-3 Resale Registration Statement Filing
IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing
IM Cannabis Corp. Announces First Quarter 2026 Financial Results
IM Cannabis Raised US$550,000 of Gross Proceeds in Convertible Note Financings
IMC Announces Receipt of Nasdaq Minimum Bid Price Notification
Stryker (NYSE:SYK) & IM Cannabis (NASDAQ:IMCC) Critical Analysis
IM Cannabis Reports 2025 Results: Revenue of C$54.7 Million with Over 134% Growth in Germany and Positive Operating Cash Flow
Analyzing Quanterix (NASDAQ:QTRX) & IM Cannabis (NASDAQ:IMCC)
IMC Announces a Strategic Entry to the Cyber Drone Interception and Satellite Intelligence Markets by Signing a Non-Binding Agreement to Acquire 51% of Blackaxe Technologies
IM Cannabis (NASDAQ:IMCC) Stock Price Down 5% – Should You Sell?
IM Cannabis (NASDAQ:IMCC) Stock Price Down 5% – What’s Next?
IM Cannabis Raises US$2,171,660.40 in Note Purchase Agreements
IM Cannabis Announces the Appointment of Mr. Alon Dayan to its Board of Directors
IM Cannabis Explores U.S. Market Entry Following President Trump's Executive Order on Increasing Medical Marijuana and Cannabidiol Research
Head-To-Head Review: IM Cannabis (NASDAQ:IMCC) versus DiaSorin (OTCMKTS:DSRLF)
IM Cannabis Appoints Asi Levi as Chief Financial Officer
IM Cannabis Reports Third Quarter 2025 Financial Results
IM Cannabis to Report third Quarter 2025 Financial Results on Thursday, November 13th at 9:00am ET
IM Cannabis Announces CFO Departure
Cannabis Investing 2025: 3 Pot Stocks to Watch Before November
IM Cannabis Signs Non-Binding Term Sheet to Acquire 60% Stake in Innovative Quantum Computing Bio Data Company for Up to $54 Million
IM Cannabis Announces Board Changes and Strategic Decision to Identify Additional Business Opportunities
IM Cannabis Regains Compliance with Nasdaq Stockholders' Equity Listing Requirement
IM Cannabis Announces Warrant Amendments and Form F-3 Resale Registration Statement Filing
IM Cannabis Reports Second Quarter 2025 Financial Results
IM Cannabis to Report Second Quarter 2025 Financial Results on Tuesday, August 12th at 9:00am ET
IM Cannabis Closes Private Placement for Gross Proceeds of Approximately US$4.1 Million
IM CANNABIS ANNOUNCES FILING OF SHELF REGISTRATION STATEMENT ON FORM F-3
IM Cannabis Announces the Signing of a Loan Agreement and Appointment of Oz Adler to Board of Directors
IM Cannabis Provides Corporate Updates
CSE Bulletin: Delist - IM Cannabis Corp. (IMCC)
IM Cannabis Announces Plans to Voluntarily Delist from the Canadian Securities Exchange
IM Cannabis Provides Corporate Updates
IM Cannabis Corp. (IMCC) Q1 2025 Earnings Call Transcript
IM Cannabis Reports First Quarter Financial Results
IM Cannabis Announces Filing of Information Circular for Upcoming Annual General and Special Meeting and Provides Additional Information on the Focus Transaction
IM Cannabis to Report First Quarter 2025 Financial Results on Thursday, May 15th at 9:00am ET
IM Cannabis Provides Corporate Updates
IM Cannabis Corp. (IMCC) Q4 2024 Earnings Call Transcript
IM Cannabis Reports Fourth Quarter and Full Year 2024 Financial Results
IM Cannabis to Report Fourth Quarter and Full Year 2024 Financial Results on Monday, March 31 2025 at 9:00am ET
IM Cannabis Announces Change of Auditors
IM Cannabis Corp. (IMCC) Q3 2024 Earnings Call Transcript
IM Cannabis Reports Third Quarter Financial Results
IM Cannabis to Report Third Quarter 2024 Financial Results on Thursday, November 14th at 9:00am ET
IM Cannabis Announces up to US$1,613,000 Private Placement Offering Led by Management
IMC Germany Announces Outstanding Preliminary Q3, 2024 Performance with 50% Growth Over Q2
IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors
IM Cannabis Corp. (IMCC) Q2 2024 Earnings Call Transcript